Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer

Clinical trial NCT06670300 · NOT_YET_RECRUITING

Trial details

NCT number

NCT06670300

Sponsor

YongZhang

Status

NOT_YET_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2024-12-01

Primary completion

2027-12-30

Enrollment

20

View on ClinicalTrials.gov